Hereditary Angioedema (HAE) References
ASCIA HP Hereditary Angioedema (HAE) References 2022188.21 KB
Abuzakouk, M., AlMahmeed, N., Memisoglu, E., McManus, M., & Alrakawi, A. (2018). Hereditary Angioedema Type II: First Presentation in Adulthood with Recurrent Severe Abdominal Pain. Case Reports Immunol, 2018, 7435870. https://doi.org/10.1155/2018/7435870
Agostoni, A., & Cicardi, M. (1992). Hereditary and Acquired C1-Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients. Medicine, 71(4). https://journals.lww.com/md-journal/fulltext/1992/07000/hereditary_and_acquired_c1_inhibitor_deficiency_.3.aspx
Agostoni, A., Aygören-Pürsün, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., Bucher, C., Castaldo, A. J., Cicardi, M., Davis, A. E., III, De Carolis, C., Drouet, C., Duponchel, C., Farkas, H., Fáy, K., Fekete, B., Fischer, B., Fontana, L., Füst, G.,…Zingale, L. (2004). Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. Journal of Allergy and Clinical Immunology, 114(3), S51-S131. https://doi.org/10.1016/j.jaci.2004.06.047
Agostoni, A., Cicardi, M., Cugno, M., Zingale, L. C., Gioffré, D., & Nussberger, J. (1999). Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology, 44(1), 21-25. https://doi.org/10.1016/S0162-3109(99)00107-1
Aygören-Pürsün, E., Bygum, A., Grivcheva-Panovska, V., Magerl, M., Graff, J., Steiner, U. C., Fain, O., Huissoon, A., Kinaciyan, T., Farkas, H., Lleonart, R., Longhurst, H. J., Rae, W., Triggiani, M., Aberer, W., Cancian, M., Zanichelli, A., Smith, W. B., Baeza, M. L.,…Cicardi, M. (2018). Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema. New England Journal of Medicine, 379(4), 352-362. https://doi.org/doi:10.1056/NEJMoa1716995
Baumgart, K. W., Britton, W. J., Kemp, A., French, M., & Roberton, D. (1997). The spectrum of primary immunodeficiency disorders in Australia. Journal of Allergy and Clinical Immunology, 100(3), 415-423. https://doi.org/10.1016/S0091-6749(97)70257-4
Bell, C. G., Kwan, E., Nolan, R. C., & Baumgart, K. W. (2008). First molecular confirmation of an Australian case of type III hereditary angioedema. Pathology - Journal of the RCPA, 40(1). https://doi.org/10.1080/00313020701716433
Bernstein, J. A., Levy, R., Wasserman, R. L., Bewtra, A., Hurewitz, D., Obtulowicz, K., Reshef, A., Kiessling, P. C., & Craig, T. J. (2008). Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema (HAE) with Human C1 Esterase Inhibitor (C1-INH): Results of a Global, Multicenter, Randomized, Placebo-controlled, Phase II/III Study (I.M.P.A.C.T.1). Journal of Allergy and Clinical Immunology, 121(3), 795. https://doi.org/10.1016/j.jaci.2008.01.052
Bonner, N., Abetz-Webb, L., Renault, L., Caballero, T., Longhurst, H., Maurer, M., Christiansen, S., Zuraw, B., For the Icatibant Outcome Survey International Executive, C., & the Hereditary Angioedema Association Medical Advisory, B. (2015). Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies. Health and Quality of Life Outcomes, 13(1), 92. https://doi.org/10.1186/s12955-015-0292-7
Bork, K., & Barnstedt, S.-E. (2001). Treatment of 193 Episodes of Laryngeal Edema With C1 Inhibitor Concentrate in Patients With Hereditary Angioedema. Archives of Internal Medicine, 161(5), 714-718. https://doi.org/10.1001/archinte.161.5.714
Bork, K., Barnstedt, S.-E., Koch, P., & Traupe, H. (2000). Hereditary angioedema with normal C1-inhibitor activity in women. The Lancet, 356(9225), 213-217. https://doi.org/10.1016/S0140-6736(00)02483-1
Bork, K., Bygum, A., & Hardt, J. (2008). Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Annals of Allergy, Asthma & Immunology, 100(2), 153-161. https://doi.org/10.1016/S1081-1206(10)60424-3
Bork, K., Frank, J., Grundt, B., Schlattmann, P., Nussberger, J., & Kreuz, W. (2007). Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). Journal of Allergy and Clinical Immunology, 119(6), 1497-1503. https://doi.org/10.1016/j.jaci.2007.02.012
Bork, K., Hardt, J., Schicketanz, K.-H., & Ressel, N. (2003). Clinical Studies of Sudden Upper Airway Obstruction in Patients With Hereditary Angioedema Due to C1 Esterase Inhibitor Deficiency. Archives of Internal Medicine, 163(10), 1229-1235. https://doi.org/10.1001/archinte.163.10.1229
Bork, K., Meng, G., Staubach, P., & Hardt, J. (2006). Hereditary Angioedema: New Findings Concerning Symptoms, Affected Organs, and Course. The American Journal of Medicine, 119(3), 267-274. https://doi.org/10.1016/j.amjmed.2005.09.064
Bork, K., Siedlecki, K., Bosch, S., Schopf, R. E., & Kreuz, W. (2000). Asphyxiation by Laryngeal Edema in Patients With Hereditary Angioedema. Mayo Clinic Proceedings, 75(4), 349-354. https://doi.org/10.4065/75.4.349
Bork, K., Staubach, P., Eckardt, A. J., & Hardt, J. (2006). Symptoms, Course, and Complications of Abdominal Attacks in Hereditary Angioedema Due to C1 Inhibitor Deficiency. Official journal of the American College of Gastroenterology | ACG, 101(3). https://doi.org/10.1111/j.1572-0241.2006.00492.x
Bork, K., Wulff, K., Witzke, G., & Hardt, J. (2017). Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII). Allergy, 72(2), 320-324. https://doi.org/10.1111/all.13076
Bouillet, L., Longhurst, H., Boccon-Gibod, I., Bork, K., Bucher, C., Bygum, A., Caballero, T., Drouet, C., Farkas, H., Massot, C., Nielsen, E. W., Ponard, D., & Cicardi, M. (2008). Disease expression in women with hereditary angioedema. American Journal of Obstetrics & Gynecology, 199(5), 484.e481-484.e484. https://doi.org/10.1016/j.ajog.2008.04.034
Bowen, T., Cicardi, M., Bork, K., Zuraw, B., Frank, M., Ritchie, B., Farkas, H., Varga, L., Zingale, L. C., Binkley, K., Wagner, E., Adomaitis, P., Brosz, K., Burnham, J., Warrington, R., Kalicinsky, C., Mace, S., McCusker, C., Schellenberg, R.,…Xiang, Z. Y. (2008). Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Annals of Allergy, Asthma & Immunology, 100(1), S30-S40. https://doi.org/10.1016/S1081-1206(10)60584-4
Boyle, R. J., Nikpour, M., & Tang, M. L. K. (2005). Hereditary angio-oedema in children: A management guideline. Pediatric Allergy and Immunology, 16(4), 288-294. https://doi.org/10.1111/j.1399-3038.2005.00275.x
Brickman, C. M., Tsokos, G. C., Balow, J. E., Lawley, T. J., Santaella, M., Hammer, C. H., & Frank, M. M. (1986). Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. J Allergy Clin Immunol, 77(5), 749-757. https://doi.org/10.1016/0091-6749(86)90424-0
Busse, P. J., Christiansen, S. C., Birmingham, J. M., Overbey, J. R., Banerji, A., Otani, I. M., Lumry, W., Goryachkovsky, A., & Zuraw, B. L. (2019). Development of a health-related quality of life instrument for patients with hereditary angioedema living in the United States. The Journal of Allergy and Clinical Immunology: In Practice, 7(5), 1679-1683.e1677. https://doi.org/10.1016/j.jaip.2018.11.042
Bygum, A., Andersen, K. E., & Mikkelsen, C. S. (2009). Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Eur J Dermatol, 19(2), 147-151. https://doi.org/10.1684/ejd.2008.0603
Campbell, D. J., Krum, H., & Esler, M. D. (2005). Losartan Increases Bradykinin Levels in Hypertensive Humans. Circulation, 111(3), 315-320. https://doi.org/10.1161/01.CIR.0000153269.07762.3B
Campos, R. A., Valle, S. O. R., & Toledo, E. C. (2021). Hereditary angioedema: a disease seldom diagnosed by pediatricians. J Pediatr (Rio J), 97 Suppl 1(Suppl 1), S10-s16. https://doi.org/10.1016/j.jped.2020.10.011
Chinniah, N., & Katelaris, C. H. (2009). Hereditary angioedema and pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology, 49(1), 2-5. https://doi.org/10.1111/j.1479-828X.2008.00945.x
Cicardi, M., Bergamaschini, L., Cugno, M., Hack, E., Agostoni, G., & Agostoni, A. (1991). Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. J Allergy Clin Immunol, 87(4), 768-773. https://doi.org/10.1016/0091-6749(91)90120-d
Cicardi, M., Castelli, R., Zingale, L. C., & Agostoni, A. (1997). Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: Comparison of treated and untreated patients. Journal of Allergy and Clinical Immunology, 99(2), 194-196. https://doi.org/10.1016/S0091-6749(97)70095-2
Cicardi, M., Zingale, L. C., Pappalardo, E., Folcioni, A., & Agostoni, A. (2003). Autoantibodies and Lymphoproliferative Diseases in Acquired C1-Inhibitor Deficiencies. Medicine, 82(4). https://doi.org/10.1097/01.md.0000085055.63483.09 Craig, T., Aygören-Pürsün, E., Bork, K., Bowen, T., Boysen, H., Farkas, H., Grumach, A., Katelaris, C. H., Lockey, R., Longhurst, H., Lumry, W., Magerl, M., Martinez-Saguer, I., Ritchie, B., Nast, A., Pawankar, R., Zuraw, B., & Maurer, M. (2012). WAO Guideline for the Management of Hereditary Angioedema. World Allergy Organ J, 5(12), 182-199. https://doi.org/10.1097/WOX.0b013e318279affa
Craig, T., Zuraw, B., Longhurst, H., Cicardi, M., Bork, K., Grattan, C., Katelaris, C., Sussman, G., Keith, P. K., Yang, W., Hébert, J., Hanzlikova, J., Staubach-Renz, P., Martinez-Saguer, I., Magerl, M., Aygören-Pürsün, E., Farkas, H., Reshef, A., Kivity, S.,…Jacobs, I. (2019). Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. The Journal of Allergy and Clinical Immunology: In Practice, 7(6), 1793-1802.e1792. https://doi.org/10.1016/j.jaip.2019.01.054
Davis, A. E., III. (2008). Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema. Annals of Allergy, Asthma & Immunology, 100(1), S7-S12. https://doi.org/10.1016/S1081-1206(10)60580-7
Dewald, G., & Bork, K. (2006). Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochemical and Biophysical Research Communications, 343(4), 1286-1289. https://doi.org/10.1016/j.bbrc.2006.03.092
Donaldson, V. H., & Evans, R. R. (1963). A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. The American Journal of Medicine, 35(1), 37-44. https://doi.org/10.1016/0002-9343(63)90162-1
Donaldson, V. H., & Rosen, F. S. (1964). Action of Complement in Hereditary Angioneurotic Edema: The Role of C′1-Esterase. The Journal of Clinical Investigation, 43(11), 2204-2213. https://doi.org/10.1172/JCI105094
Eidelman, F. J. (2010). Hereditary angioedema: New therapeutic options for a potentially deadly disorder. BMC Hematology, 10(1), 3. https://doi.org/10.1186/1471-2326-10-3
Farkas, H., Czaller, I., Csuka, D., Vas, A., Valentin, S., Varga, L., Széplaki, G., Jakab, L., Füst, G., Prohászka, Z., Harmat, G., Visy, B., & Karádi, I. (2010). The effect of long-term danazol prophylaxis on liver function in hereditary angioedema—a longitudinal study. European Journal of Clinical Pharmacology, 66(4), 419-426. https://doi.org/10.1007/s00228-009-0771-z
Farkas, H., Harmat, G., Füst, G., Varga, L., & Visy, B. (2002). Clinical management of hereditary angio-oedema in children. Pediatric Allergy and Immunology, 13(3), 153-161. https://doi.org/10.1034/j.1399-3038.2002.01014.x
Farkas, H., Martinez-Saguer, I., Bork, K., Bowen, T., Craig, T., Frank, M., Germenis, A. E., Grumach, A. S., Luczay, A., Varga, L., & Zanichelli, A. (2017). International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy, 72(2), 300-313. https://doi.org/10.1111/all.13001
Farkas, H., Varga, L., Széplaki, G. b., Visy, B. t., Harmat, G., & Bowen, T. (2007). Management of Hereditary Angioedema in Pediatric Patients. Pediatrics, 120(3), e713-e722. https://doi.org/10.1542/peds.2006-3303
Farkas, H., Zotter, Z., Csuka, D., Szabó, E., Nébenfűhrer, Z., Temesszentandrási, G., Jakab, L., Varga, L., Harmat, G., & Karádi, I. (2012). Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--a long-term survey. Allergy, 67(12), 1586-1593. https://doi.org/10.1111/all.12032
Fragnan, N., Tolentino, A. L. N., Borba, G. B., Oliveira, A. C., Simões, J. A., Palma, S. M. U., Constantino-Silva, R. N., & Grumach, A. S. (2018). Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases). Braz J Med Biol Res, 51(12), e7813. https://doi.org/10.1590/1414-431x20187813
Frank, M. M. (1979). Effect of sex hormones on the complement-related clinical disorder of hereditary angioedema. Arthritis & Rheumatism, 22(11), 1295-1299. https://doi.org/10.1002/art.1780221118
Frank, M. M. (2000). Urticaria and angioedema. In: Goldman L, Bennett JC, editors. Cecil Textbook of Medicine. 21st ed. W. B. Saunders Co
Frank, M. M. (2006). Hereditary Angioedema: The Clinical Syndrome and its Management in the United States. Immunology and Allergy Clinics of North America, 26(4), 653-668. https://doi.org/10.1016/j.iac.2006.09.005
Frank, M. M. (2008). Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema. Annals of Allergy, Asthma & Immunology, 100(1), S23-S29. https://doi.org/10.1016/S1081-1206(10)60583-2
Frank, M. M., Gelfand, J. A., & Atkinson, J. P. (1976). Hereditary Angioedema: the Clinical Syndrome and Its Management. Annals of Internal Medicine, 84(5), 580-593. https://doi.org/10.7326/0003-4819-84-5-580
Germenis, A. E., Margaglione, M., Pesquero, J. B., Farkas, H., Cichon, S., Csuka, D., Lera, A. L., Rijavec, M., Jolles, S., Szilagyi, A., Trascasa, M. L., Veronez, C. L., Drouet, C., & Zamanakou, M. (2020). International Consensus on the Use of Genetics in the Management of Hereditary Angioedema. J Allergy Clin Immunol Pract, 8(3), 901-911. https://doi.org/10.1016/j.jaip.2019.10.004
Gompels, M. M., Lock, R. J., Abinun, M., Bethune, C. A., Davies, G., Grattan, C., Fay, A. C., Longhurst, H. J., Morrison, L., Price, A., Price, M., & Watters, D. (2005). C1 inhibitor deficiency: consensus document. Clinical and Experimental Immunology, 139(3), 379-394. https://doi.org/10.1111/j.1365-2249.2005.02726.x
Graves, R. (1843). Clinical lectures on the practice of medicine, in Major, R.H., ed. (1955) (3rd ed.). Charles C. Thomas Pub Ltd, 623- 624.
Guan, X., Sheng, Y., Liu, S., He, M., Chen, T., & Zhi, Y. (2024). Epidemiology, economic, and humanistic burden of hereditary angioedema: a systematic review. Orphanet Journal of Rare Diseases, 19(1), 256. https://doi.org/10.1186/s13023-024-03265-z
Gülbahar, O. (2021). Angioedema without wheals: a clinical update. Balkan Med J, 38(2), 73-81. https://doi.org/10.5152/balkanmedj.2021.20060
Jurado-Palomo, J., Muñoz-Caro, J. M., López-Serrano, M. C., Prior, N., Cabañas, R., Pedrosa, M., Burgueño, M., & Caballero, T. (2013). Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency. J Investig Allergol Clin Immunol, 23(1), 1-6. http://www.jiaci.org/issues/vol23issue1/1.pdf
Landerman, N. S. (1962). Hereditary angioneurotic edema: I. Case reports and review of the literature. Journal of Allergy, 33(4), 316-329. https://doi.org/10.1016/0021-8707(62)90031-X
Li, H. H. (2020). Hereditary angioedema: Long-term prophylactic treatment. Allergy Asthma Proc, 41(Suppl 1), S35-s37. https://doi.org/10.2500/aap.2020.41.200092
Longhurst, H. J. (2005). Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? International Journal of Clinical Practice, 59(5), 594-599. https://doi.org/10.1111/j.1742-1241.2005.00352.x
Longhurst, H., Cicardi, M., Craig, T., Bork, K., Grattan, C., Baker, J., Li, H. H., Reshef, A., Bonner, J., Bernstein, J. A., Anderson, J., Lumry, W. R., Farkas, H., Katelaris, C. H., Sussman, G. L., Jacobs, J., Riedl, M., Manning, M. E., Hebert, J.,…Zuraw, B. L. (2017). Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. N Engl J Med, 376(12), 1131-1140. https://doi.org/10.1056/NEJMoa1613627
Magerl, M. A. K., Riedl, M. A., Newcomer, S. D., Supina, D., & Krishnarajah, G. (2018). The Predictability of Attacks in Patients with Hereditary Angioedema. Journal of Allergy and Clinical Immunology, 141(2), AB57. https://doi.org/10.1016/j.jaci.2017.12.184
Magerl, M., Germenis, A. E., Maas, C., & Maurer, M. (2017). Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment. Immunology and Allergy Clinics of North America, 37(3), 571-584. https://doi.org/10.1016/j.iac.2017.04.004
Maurer, M., Longhurst, H. J., Fabien, V., Li, H. H., & Lumry, W. R. (2014). Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world setting. Allergy Asthma Proc, 35(5), 377-381. https://doi.org/10.2500/aap.2014.35.3780
Maurer, M., Magerl, M., Ansotegui, I., Aygören-Pürsün, E., Betschel, S., Bork, K., Bowen, T., Boysen, H. B., Farkas, H., Grumach, A. S., Hide, M., Katelaris, C., Lockey, R., Longhurst, H., Lumry, W. R., Martinez-Saguer, I., Moldovan, D., Nast, A., Pawankar, R.,…Craig, T. (2018). The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update. World Allergy Organization Journal, 11. https://doi.org/10.1186/s40413-017-0180-1
Mendivil, J., DerSarkissian, M., Banerji, A., Diwakar, L., Katelaris, C. H., Keith, P. K., Kim, H., Lacuesta, G., Magerl, M., Slade, C., Smith, W. B., Choudhry, Z., Simon, A., Sarda, S. P., & Busse, P. J. (2023). A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis. Allergy, Asthma & Clinical Immunology, 19(1), 48. https://doi.org/10.1186/s13223-023-00795-2
Miranda, A. R., Ue, A. P., Sabbag, D. V., Furlani Wde, J., Souza, P. K., & Rotta, O. (2013). Hereditary angioedema type III (estrogen-dependent) report of three cases and literature review. An Bras Dermatol, 88(4), 578-584. https://doi.org/10.1590/abd1806-4841.20131818
Nzeako, U. C., Frigas, E., & Tremaine, W. J. (2001). Hereditary Angioedema: A Broad Review for Clinicians. Archives of Internal Medicine, 161(20), 2417-2429. https://doi.org/10.1001/archinte.161.20.2417
O'Bier, A., Muñiz, A. E., & Foster, R. L. (2005). Hereditary Angioedema Presenting as Epiglottitis. Pediatric Emergency Care, 21(1). https://doi.org/10.1097/01.pec.0000150985.81109.0d
Osler, W. (2010). Landmark Publication from The American Journal of the Medical Sciences: Hereditary Angio-Neurotic Oedema. The American Journal of the Medical Sciences, 339(2), 175-178. https://doi.org/10.1097/MAJ.0b013e3181b2803f
Postnikoff, I. M., & Pritzker, K. P. H. (1979). Hereditary Angioneurotic Edema: An Unusual Case of Maternal Mortality. Journal of Forensic Sciences, 24(2), 473-478. https://doi.org/10.1520/JFS10855J
Prematta, M. J., Kemp, J. G., Gibbs, J. G., Mende, C., Rhoads, C., & Craig, T. J. (2009). Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. Allergy Asthma Proc, 30(5), 506-511. https://doi.org/10.2500/aap.2009.30.3279
Prematta, M. J., Prematta, T., & Craig, T. J. (2008). Treatment of hereditary angioedema with plasma-derived C1 inhibitor. Ther Clin Risk Manag, 4(5), 975-982. https://doi.org/10.2147/tcrm.s3172
Prior, N., Remor, E., Gómez-Traseira, C., López-Serrano, C., Cabañas, R., Contreras, J., Campos, Á., Cardona, V., Cimbollek, S., González-Quevedo, T., Guilarte, M., de Rojas, D. H., Marcos, C., Rubio, M., Tejedor-Alonso, M., & Caballero, T. (2012). Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project. Health Qual Life Outcomes, 10, 82. https://doi.org/10.1186/1477-7525-10-82
Quincke, H. (1882). Acute circumscribed edema of the skin. Monatsh-Prakt. Derm, 1, 129-131.
Riedl, M. A., Johnston, D. T., Anderson, J., Meadows, J. A., Soteres, D., LeBlanc, S. B., Wedner, H. J., & Lang, D. M. (2022). Optimization of care for patients with hereditary angioedema living in rural areas. Annals of Allergy, Asthma & Immunology, 128(5), 526-533. https://doi.org/10.1016/j.anai.2021.09.026
Roche, O., Blanch, A., Caballero, T., Sastre, N., Callejo, D., & López-Trascasa, M. (2005). Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Annals of Allergy, Asthma & Immunology, 94(4), 498-503. https://doi.org/10.1016/S1081-1206(10)61121-0
Rosen, F. S., Charache, P., Pensky, J., & Donaldson, V. (1965). Hereditary Angioneurotic Edema: Two Genetic Variants. Science, 148(3672), 957-958. https://doi.org/doi:10.1126/science.148.3672.957
Széplaki, G., Varga, L., Valentin, S., Kleiber, M., Karádi, I., Romics, L., Füst, G., & Farkas, H. (2005). Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. Journal of Allergy and Clinical Immunology, 115(4), 864-869. https://doi.org/10.1016/j.jaci.2004.12.1130
Trainotti, S., Johnson, F., Hahn, J., Hofauer, B., Greve, J., Wollenberg, B., Hoffmann, T. K., & Lochbaum, R. (2023). Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH) 2014; A Bicenter Retrospective Study on Diagnosis, Course, and Therapy. The Journal of Allergy and Clinical Immunology: In Practice, 11(12), 3772-3779. https://doi.org/10.1016/j.jaip.2023.09.003
Valerieva, A., & Longhurst, H. J. (2022). Treatment of hereditary angioedema-single or multiple pathways to the rescue. Front Allergy, 3, 952233. https://doi.org/10.3389/falgy.2022.952233
Weller, K., Groffik, A., Magerl, M., Tohme, N., Martus, P., Krause, K., Metz, M., Staubach, P., & Maurer, M. (2012). Development and construct validation of the angioedema quality of life questionnaire. Allergy, 67(10), 1289-1298. https://doi.org/10.1111/all.12007
Weller, K., Magerl, M., Peveling-Oberhag, A., Martus, P., Staubach, P., & Maurer, M. (2016). The Angioedema Quality of Life Questionnaire (AE-QoL) – assessment of sensitivity to change and minimal clinically important difference. Allergy, 71(8), 1203-1209. https://doi.org/10.1111/all.12900
Winnewisser, J., Rossi, M., SpÄTh, P., & BÜRgi, H. (1997). Type I hereditary angio-oedema. Variability of clinical presentation and course within two large kindreds. Journal of Internal Medicine, 241(1), 39-46. https://doi.org/10.1046/j.1365-2796.1997.76893000.x
Wu, M. A. (2019). Lanadelumab for the treatment of hereditary angioedema. Expert Opinion on Biological Therapy, 19(12), 1233-1245. https://doi.org/10.1080/14712598.2019.1685490
Zarnowski, J., & Treudler, R. (2024). Dietary and physical trigger factors in hereditary angioedema: Self-conducted investigation and literature overview. Allergol Select, 8, 358-364. https://doi.org/10.5414/alx02523e
Zingale, L. C., Beltrami, L., Zanichelli, A., Maggioni, L., Pappalardo, E., Cicardi, B., & Cicardi, M. (2006). Angioedema without urticaria: a large clinical survey. Canadian Medical Association Journal, 175(9), 1065-1070. https://doi.org/10.1503/cmaj.060535
Zuraw, B. L. (2008). Hereditary Angioedema. New England Journal of Medicine, 359(10), 1027-1036. https://doi.org/doi:10.1056/NEJMcp0803977
Zuraw, B. L. (2018). Hereditary angioedema with normal C1 inhibitor: Four types and counting. Journal of Allergy and Clinical Immunology, 141(3), 884-885. https://doi.org/10.1016/j.jaci.2018.01.015
Zuraw, B. L., & Herschbach, J. (2000). Detection of C1 inhibitor mutations in patients with hereditary angioedema. Journal of Allergy and Clinical Immunology, 105(3), 541-546. https://doi.org/10.1067/mai.2000.104780
Zuraw, B., Lumry, W., Banerji, A., Aygoren-Pursun, E., Bernstein, J., Johnston, D., Christiansen, S., Riedl, M., Cicardi, M., Maurer, M., Cornpropst, M., Dobo, S., Iocca, H., Nagy, E., Murray, S., Collis, P., & Sheridan, W. (2019). P150 ORAL PROPHYLAXIS WITH BCX7353 REDUCES HAE ATTACK RATES AND IS WELL-TOLERATED: APEX-2 STUDY RESULTS. Annals of Allergy, Asthma & Immunology, 123(5), S27. https://doi.org/10.1016/j.anai.2019.08.254
NOTE: There is a separate ASCIA reference list for Immunodeficiency publications on the ASCIA website www.allergy.org.au/hp/papers#p4
Content updated May 2025